Axoltis Pharma announces to attend MJFF 2019 Parkinson’s Disease Therapeutics Conference on October 15th at New York City, NY, USA. This meeting is The Michael J. Fox Foundation’s annual scientific conference and the only one in the world focused exclusively on Parkinson’s disease drug development. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.